drugset / Trial / NCT00802308

Effects of a Single Dose of Egalet® Morphine Combined With a Single Dose of Alcohol in Healthy Moderate Drinkers

NCT00802308

Phase 1 Completed 24 enrolled Egalet Ltd
RandomizedCrossoverSingle-blind

Summary

The purpose of the study is to evaluate the pharmacokinetics of Egalet® morphine when administered with alcohol and compare to administration with water.

Timeline

Start
2008-12
Primary completion
2009-02
Completion
2009-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Morphine Other / unclassified

Indications

No indication recorded.